Phenotypic Resistance Testing

Gag Mutations Identified in Wild-type HIV-1 that Impact Viral Replication Capacity (RC) May Represent Cytotoxic T-Lymphocyte (CTL) Escape Mutations 6-27-05

Susceptibility Measurements Using Resistance Test Vectors with or without Patient-Derived C-terminus of RT, RNAseH and Integrase Are Largely Concordant 6-27-05

Properties of In Vitro Generated HIV-1 Variants Resistant to the CCR5 Antagonists  SCH 351125 and SCH 417690 6-17-05

Determination of Phenotypic Clinical Cutoffs for Atazanavir and Atazanavir/Ritonavir 6-15-05

Reduced Susceptibility to Protease Inhibitors (PI) in the Absence of Primary PI Resistance-Associated Mutations 6-15-05

Return to Conference Main Page